Valuation: Ambu A/S

Market Cap 19.59B 2.94B 2.62B 2.43B 2.21B 4.14B 279B 4.21B 29.13B 11.46B 146B 11.04B 10.8B 466B P/E 2026 *
31.7x
P/E 2027 * 24.6x
Enterprise Value 18.95B 2.85B 2.54B 2.35B 2.14B 4.01B 270B 4.07B 28.18B 11.08B 141B 10.67B 10.45B 451B EV / Sales 2026 *
2.95x
EV / Sales 2027 * 2.6x
Free-Float
86.18%
Yield 2026 *
0.58%
Yield 2027 * 0.85%
1 day-4.21%
Current month+8.85%
1 month+14.14%
3 months+8.61%
6 months+6.00%
Current year-14.72%
1 week 75.05
Extreme 75.05
79.45
1 month 64.2
Extreme 64.2
79.45
Current year 56.25
Extreme 56.25
92.15
1 year 56.25
Extreme 56.25
109
3 years 56.25
Extreme 56.25
154.6
5 years 56.25
Extreme 56.25
201.7
10 years 52
Extreme 52
358.7
Manager TitleAgeSince
Chief Executive Officer 53 2022-05-19
Director of Finance/CFO 42 2023-12-31
Chief Operating Officer 53 2024-06-09
Director TitleAgeSince
Chairman 58 2020-12-08
Director/Board Member 58 2021-12-13
Director/Board Member 63 2021-12-13
Date Insider Type Main position Quantity % Market Cap. Importance
12/4/25 Buy

Chief Financial Officer

10,500 0.0045%
11/7/25 Buy

Chief Executive Officer

20,000 0.0583%
11/7/25 Buy

Chief Executive Officer

20,000 0.0583%
Change 5-day change 1-year change 3-year change Capi.($)
-4.21%0.00%-28.73%+9.37% 3.08B
-0.79%+2.20%-19.04%+9.03% 181B
-2.09%+0.91%-3.14%+28.22% 116B
+1.11%+5.43%-20.43%+11.00% 113B
-1.52%+3.61%-51.34%-6.22% 79.83B
-0.27%+4.60%+4.72%+79.05% 65.06B
-0.49%+0.51%+12.66%+74.10% 54.35B
-0.53%+0.98%+0.87%-25.92% 52.23B
-0.81%+6.08%-12.53%+30.57% 44.15B
-0.07%+0.07%+29.10%-0.07% 32.47B
Average -0.97%+4.07%-8.79%+20.91% 74.17B
Weighted average by Cap. -0.68%+3.42%-11.98%+20.02%

Financials

2026 *2027 *
Net sales 6.43B 966M 861M 797M 725M 1.36B 91.56B 1.38B 9.56B 3.76B 47.85B 3.62B 3.55B 153B 7.19B 1.08B 962M 892M 811M 1.52B 102B 1.55B 10.69B 4.2B 53.5B 4.05B 3.97B 171B
Net income 626M 94.02M 83.81M 77.64M 70.59M 132M 8.91B 135M 931M 366M 4.66B 353M 345M 14.89B 797M 120M 107M 98.85M 89.87M 169M 11.35B 171M 1.19B 466M 5.93B 449M 440M 18.96B
Net Debt -640M -96.07M -85.64M -79.33M -72.13M -135M -9.11B -138M -952M -374M -4.76B -360M -353M -15.22B -863M -130M -116M -107M -97.32M -183M -12.29B -186M -1.28B -505M -6.42B -486M -476M -20.53B
Projected Income Statement - Annual - Ambu A/S
Logo Ambu A/S
Ambu A/S is specialized in the design, production and marketing of medical supplies. Net sales break down by family of products as follows: - emergency care and resuscitation devices (50.8%): mechanical ventilation devices (insufflators, laryngeal masks, facial masks and respiratory bags), secretion aspirators, immobilization devices, etc. In addition, the group sells dummies for first aid training centers; - single-use endoscopes (30.2%); - monitoring and diagnostic devices (19%): including electrodes used in the fields of cardiology, neurophysiology and first aid. At the end of September 2025, Ambu A/S had four production sites located in China, Malaysia, the United States and Mexico. Net sales are distributed geographically as follows: Denmark (1%), Europe (38.9%), the United States (49.3%), North America (1.2%) and other (9.6%).
Employees
5,200
Date Price Change Volume
26-10-19 DKK 75.05 -4.21% 1,037,387
26-10-16 DKK 78.35 +0.51% 817,309
26-10-15 DKK 77.95 +1.43% 479,154
26-10-14 DKK 76.85 +0.85% 543,125
26-10-13 DKK 76.20 +1.53% 454,002
Trader
Investor
Global
Quality
ESG MSCI
BBB
MarketScreener Ratings - Ambu A/S
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
8
Last Close Price
75.05DKK
Average target price
81.10DKK
Spread / Average Target
+8.06%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Ambu A/S
  1. Stock Market
  2. Stocks
  3. AMBU B Stock